Science and technology | Brains in a pill

Study drugs make healthy people worse at problem-solving, not better

Users try harder, but are less competent

A student with a prescription for Adderall shares with a classmate.
Image: Robert Stolarik/The New York Times/Redux/Eyevine

FOR MORE than six months Americans have been struggling to get their hands on medications like dextroamphetamine (better known as Adderall) and methylphenidate (Ritalin). Officially, these stimulant drugs are used to treat attention-deficit hyperactivity disorder (ADHD).

Unofficially, the drugs are also popular with devotees of “nootropics”—chemicals that supposedly boost brainpower. Students and workers in industries from tech to finance take the medications in the hope they will improve their concentration and ability to get things done. But a new paper suggests that this may be ill-advised. The drugs seem to make people slightly worse at solving problems, not better.

This article appeared in the Science & technology section of the print edition under the headline "Hard-working, but incompetent"

The trouble with sticky inflation

From the June 24th 2023 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Science and technology

To stay fit, future Moon-dwellers will need special workouts

Running around the inside of a barrel might help

Wind turbines keep getting bigger

That poses a giant transport problem